FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024751340> ?p ?o ?g. }

• W2024751340 endingPage "e0119160" @default.
• W2024751340 startingPage "e0119160" @default.
• W2024751340 abstract "Galectin-3 (Gal-3) is considered as a myocardial fibrosis biomarker with prognostic value in heart failure (HF). Since aldosterone is a neurohormone with established fibrotic properties, we aimed to investigate if mineralocorticoid receptor antagonists (MRAs) would modulate the prognostic value of Gal-3.The IBLOMAVED cohort comprised 427 eligible chronic HF patients (CHF) with echocardiography and heart failure biomarkers assessments (BNP). After propensity score matching CHF patients for cardiovascular risk factors, to form balanced groups, Gal-3 levels were measured at baseline in plasma from patients treated with MRAs (MRA-Plus, n=101) or not (MRA-Neg, n=101). The primary end point was all-cause mortality with a follow-up of 3 years.Gal-3 in plasma from these patients were similar with median values of 14.0 ng/mL [IQR, 9.9-19.3] and 14.4 ng/mL [IQR, 12.3-19.8] (P = 0.132) in MRA-Neg and MRA-Plus, respectively. Patients with Gal-3 ≤17.8 ng/mL had an HR of 1 (reference group) and 1.5 [0.4-5.7] in MRA-Neg and MRA-Plus, respectively (p=0.509). Patients with Gal-3 ≥ 17.8 ng/mL had an HR of 7.4 [2.2-24.6] and 9.0 [2.9-27.8] in MRA-Plus and MRA-Neg, respectively (p=0.539) and a median survival time of 2.4 years [95%CI,1.8-2.4]. Multivariate Cox proportional hazard analysis confirmed that MRA and the interaction term between MRA treatment and Gal-3 >17.8 ng/mL were not factors associated with survival.MRA treatment did not impair the prognostic value of Gal-3 assessed with a 17.8 ng/mL cut off. Gal-3 levels maintained its strong prognostic value in CHF also in patients treated with MRAs. The significance of the observed lack of an interaction between Gal-3 and treatment effect of MRAs remains to be elucidated." @default.
• W2024751340 created "2016-06-24" @default.
• W2024751340 creator A5020978931 @default.
• W2024751340 creator A5026656942 @default.
• W2024751340 creator A5031658795 @default.
• W2024751340 creator A5033703477 @default.
• W2024751340 creator A5042127120 @default.
• W2024751340 creator A5050924389 @default.
• W2024751340 creator A5055964525 @default.
• W2024751340 creator A5058448908 @default.
• W2024751340 creator A5061303392 @default.
• W2024751340 creator A5085984518 @default.
• W2024751340 creator A5091514921 @default.
• W2024751340 date "2015-03-18" @default.
• W2024751340 modified "2023-10-02" @default.
• W2024751340 title "The Prognostic Value of Plasma Galectin-3 in Chronic Heart Failure Patients Is Maintained when Treated with Mineralocorticoid Receptor Antagonists" @default.
• W2024751340 cites W1638424324 @default.
• W2024751340 cites W1969343364 @default.
• W2024751340 cites W1969497556 @default.
• W2024751340 cites W1998227490 @default.
• W2024751340 cites W2003254802 @default.
• W2024751340 cites W2014097940 @default.
• W2024751340 cites W2015404118 @default.
• W2024751340 cites W2030020451 @default.
• W2024751340 cites W2031143081 @default.
• W2024751340 cites W2034759328 @default.
• W2024751340 cites W2037419267 @default.
• W2024751340 cites W2041798293 @default.
• W2024751340 cites W2048178709 @default.
• W2024751340 cites W2065031087 @default.
• W2024751340 cites W2080698057 @default.
• W2024751340 cites W2090158969 @default.
• W2024751340 cites W2091607902 @default.
• W2024751340 cites W2093044893 @default.
• W2024751340 cites W2094188666 @default.
• W2024751340 cites W2100276747 @default.
• W2024751340 cites W2102815431 @default.
• W2024751340 cites W2106493153 @default.
• W2024751340 cites W2111635289 @default.
• W2024751340 cites W2119340816 @default.
• W2024751340 cites W2123248199 @default.
• W2024751340 cites W2135164569 @default.
• W2024751340 cites W2135350140 @default.
• W2024751340 cites W2138377896 @default.
• W2024751340 cites W2139571734 @default.
• W2024751340 cites W2139577967 @default.
• W2024751340 cites W2142280282 @default.
• W2024751340 cites W2143795945 @default.
• W2024751340 cites W2148910374 @default.
• W2024751340 cites W2161321429 @default.
• W2024751340 cites W2166805849 @default.
• W2024751340 cites W2323458614 @default.
• W2024751340 cites W2330906100 @default.
• W2024751340 cites W3023363600 @default.
• W2024751340 cites W36552519 @default.
• W2024751340 cites W38585076 @default.
• W2024751340 doi "https://doi.org/10.1371/journal.pone.0119160" @default.
• W2024751340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4364698" @default.
• W2024751340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25786035" @default.
• W2024751340 hasPublicationYear "2015" @default.
• W2024751340 type Work @default.
• W2024751340 sameAs 2024751340 @default.
• W2024751340 citedByCount "18" @default.
• W2024751340 countsByYear W20247513402016 @default.
• W2024751340 countsByYear W20247513402017 @default.
• W2024751340 countsByYear W20247513402018 @default.
• W2024751340 countsByYear W20247513402019 @default.
• W2024751340 countsByYear W20247513402020 @default.
• W2024751340 countsByYear W20247513402021 @default.
• W2024751340 countsByYear W20247513402022 @default.
• W2024751340 crossrefType "journal-article" @default.
• W2024751340 hasAuthorship W2024751340A5020978931 @default.
• W2024751340 hasAuthorship W2024751340A5026656942 @default.
• W2024751340 hasAuthorship W2024751340A5031658795 @default.
• W2024751340 hasAuthorship W2024751340A5033703477 @default.
• W2024751340 hasAuthorship W2024751340A5042127120 @default.
• W2024751340 hasAuthorship W2024751340A5050924389 @default.
• W2024751340 hasAuthorship W2024751340A5055964525 @default.
• W2024751340 hasAuthorship W2024751340A5058448908 @default.
• W2024751340 hasAuthorship W2024751340A5061303392 @default.
• W2024751340 hasAuthorship W2024751340A5085984518 @default.
• W2024751340 hasAuthorship W2024751340A5091514921 @default.
• W2024751340 hasBestOaLocation W20247513401 @default.
• W2024751340 hasConcept C126322002 @default.
• W2024751340 hasConcept C126894567 @default.
• W2024751340 hasConcept C164705383 @default.
• W2024751340 hasConcept C189135053 @default.
• W2024751340 hasConcept C207103383 @default.
• W2024751340 hasConcept C2776336362 @default.
• W2024751340 hasConcept C2778198053 @default.
• W2024751340 hasConcept C2778525890 @default.
• W2024751340 hasConcept C2781197716 @default.
• W2024751340 hasConcept C44249647 @default.
• W2024751340 hasConcept C50382708 @default.
• W2024751340 hasConcept C55493867 @default.
• W2024751340 hasConcept C71924100 @default.
• W2024751340 hasConcept C72563966 @default.
• W2024751340 hasConcept C86803240 @default.

• next